J, L., S, C., M, Z., Y, G., & Y, Z. (2025). Pharmacovigilance and signal detection of adverse drug events associated with proteasome inhibitors in multiple myeloma: A real-world analysis using the FAERS database. Hematology (Amsterdam, Netherlands), 30(1), 2534758. https://doi.org/10.1080/16078454.2025.2534758
Chicago Style (17th ed.) CitationJ, Luo, Chen S, Zhang M, Gao Y, and Zeng Y. "Pharmacovigilance and Signal Detection of Adverse Drug Events Associated with Proteasome Inhibitors in Multiple Myeloma: A Real-world Analysis Using the FAERS Database." Hematology (Amsterdam, Netherlands) 30, no. 1 (2025): 2534758. https://doi.org/10.1080/16078454.2025.2534758.
MLA (9th ed.) CitationJ, Luo, et al. "Pharmacovigilance and Signal Detection of Adverse Drug Events Associated with Proteasome Inhibitors in Multiple Myeloma: A Real-world Analysis Using the FAERS Database." Hematology (Amsterdam, Netherlands), vol. 30, no. 1, 2025, p. 2534758, https://doi.org/10.1080/16078454.2025.2534758.